Categories: News

SMPP Enters into Teaming Agreement with KNDS for KATANA

SMPP, one of India’s leading defence and aerospace companies, has entered into a teaming agreement through its subsidiary SMPP Ammunition with KNDS for the KATANA® range of precision-guided artillery ammunition. The KATANA® is a 155mm precision-guided munition designed to deliver high accuracy and extended range, addressing critical operational needs of modern artillery systems. The agreement was signed on 20th November 2025 at Milipol Exhibition in Paris.

- Advertisement -

 

- Advertisement -

Finalisation of Teaming agreement by SMPP with KNDS

- Advertisement -

 

- Advertisement -

The KATANA® family product includes KATANA® Ballistic Range (BR), Extended Range (ER) and High Precision (HP) with laser seeker ammunition. The KATANA family of ammunition offers a full-calibre Precision Guided Munition with extended capabilities to address armoured threats with decametric-level precision and leverages a hybrid guidance system that combines multi-constellation receiver (GNSS) and an Inertial Measurement Unit (IMU) to ensure accuracy across diverse terrains and combat environments. A future variant is expected to incorporate a semi-active laser seeker to achieve metric-level precision for even more demanding mission profiles. The fire-and-forget capability further enhances its effectiveness in complex operational scenarios, including densely populated urban areas.

- Advertisement -

 

- Advertisement -

Under the teaming agreement, SMPP and KNDS will focus on offering the KATANA® family of ammunition to the Indian Army under the Make in India policy, strengthening India’s capability in advanced artillery ammunition and addressing a key operational requirement for the Indian Armed Forces. This agreement comes at a time when the Indian Army has an extensive and urgent requirement for 155mm artillery systems and ammunition.

- Advertisement -

 

- Advertisement -

SMPP Limited, founded in 1985, is one of India’s leading defence and aerospace manufacturers with a diverse product portfolio that includes personnel protection, platform armouring, medium & large calibre ammunition & unmanned aerial systems (armed/ surveillance) and their respective payloads. The company is actively expanding into new areas critical to India’s defence preparedness. Headquartered in New Delhi, SMPP operates advanced manufacturing facilities in Haryana and Himachal Pradesh.

- Advertisement -

 

- Advertisement -

KNDS Ammo France belongs to KNDS Group which is a European land defence systems leader. As prime contractor and lead system integrator KNDS develop, deliver and sustain state of the art manned and unmanned ‘system-of-systems’, complete mission solutions and its main systems and sub-platforms, including the related ammunitions and services.

- Advertisement -
News Voir

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

2 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

1 week ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

4 weeks ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago